Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,222 public trials 542 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

NCT07091630

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama at Birmingham - 1720 University Blvd Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. (S corporation) Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Medstar Health Research Institute Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

NCT07501702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Neurology Offices Boca Raton, Florida, United States
  • SFM Clinical Reseach, LLC Boca Raton, Florida, United States
  • Homestead Associates in Research Homestead, Florida, United States
  • UF Health Jacksonville Respiratory Therapy (PFT and DLCO) Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 103 locations
View Trial Details
Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • TG Therapeutics Investigational Trial Site Birmingham, Alabama, United States
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
  • TG Therapeutics Investigational Trial Site Gilbert, Arizona, United States
View all 91 locations
View Trial Details

Related conditions